BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okabe H, Yamashita Y, Inoue R, Kinoshita S, Itoyama R, Yusa T, Nakao Y, Yamao T, Umezaki N, Tsukamoto M, Kitano Y, Miyata T, Arima K, Hayashi H, Imai K, Chikamoto A, Baba H. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. Surg Today 2020;50:193-9. [DOI: 10.1007/s00595-019-01866-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Tsunematsu M, Gocho T, Yanagaki M, Shirai Y, Haruki K, Furukawa K, Yasuda J, Onda S, Sakamoto T, Ikegami T. The impact of postoperative exocrine index on non‐alcoholic fatty liver disease following pancreaticoduodenectomy. Annals of Gastroent Surgery. [DOI: 10.1002/ags3.12572] [Reference Citation Analysis]
2 Kato H, Kamei K, Suto H, Misawa T, Unno M, Nitta H, Satoi S, Kawabata Y, Ohtsuka M, Rikiyama T, Sudo T, Matsumoto I, Okano K, Suzuki Y, Sata N, Isaji S, Sugiyama M, Takeyama Y. Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: A first multicenter prospective study in Japan. J Hepatobiliary Pancreat Sci 2021. [PMID: 34863034 DOI: 10.1002/jhbp.1093] [Reference Citation Analysis]
3 Flick KF, Al-Temimi MH, Maatman TK, Sublette CM, Swensson JK, Nakeeb A, Ceppa EP, Nguyen TK, Schmidt CM, Zyromski NJ, Tann MA, House MG. Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy. J Gastrointest Surg 2020;24:2008-14. [PMID: 32671796 DOI: 10.1007/s11605-020-04723-2] [Reference Citation Analysis]
4 Klose J, Ronellenfitsch U, Kleeff J. Management problems in patients with pancreatic cancer from a surgeon's perspective. Semin Oncol 2021:S0093-7754(21)00014-2. [PMID: 34059343 DOI: 10.1053/j.seminoncol.2021.02.008] [Reference Citation Analysis]